Measurable residual disease by multiparametric flow cytometry in acute lymphoblastic leukemia
1:02:00
Combining Pathology, MammaPrint and BluePrint
1:01:22
What to Know About Minimal Residual Disease | LRF Webinars
1:34:54
13. Flow cytometry in acute leukaemias – Dr Timothy Farren
9:03
ICCS Education: Minimal/Measurable Residual Disease Testing (MRD) by Flow Cytometry in BLL
56:44
40 years of MRD. A review of flow cytometry as an advanced technique for B-ALL monitoring
58:18
Implementation of FDA-cleared tumor profiling assay to enable localized Precision Oncology testing
1:22:33
Update on Minimal Residual Disease in Paediatric Leukemia Recording
1:01:32